Category: Publications

Posted on

Article: Will Naked Short Sellers Torpedo The Trump Bull Market?

Article - Media

Will Naked Short Sellers Torpedo The Trump Bull Market?

Richard Levick

Forbes, 26 September 2018

Nevermind the succession of new tariffs that beclouds the prospect of sustained economic growth. Some observers believe even greater threats to the “Trump Rally” are rooted deep within our financial markets – specifically, in the sort of systematized and pandemic short-selling that can roil market innovators like Tesla, not to mention small and midcap companies that are much more vulnerable to manipulation. One might wonder which burgeoning new industries are on the current hit list. Publicly traded marijuana companies are mentioned often.

Paywall Access to Full Article

Posted on

Article: DoorDash customers say their accounts have been hacked

Article - Media, Publications

DoorDash customers say their accounts have been hacked

Zack Whittaker, 26 September 2018

Food delivery startup DoorDash has received dozens of complaints from customers who say their accounts have been hacked.

Dozens of people have tweeted at @DoorDash with complaints that their accounts had been improperly accessed and had fraudulent food deliveries charged to their account. In many cases, the hackers changed their email addresses so that the user could not regain access to their account until they contacted customer services. Yet, many said that they never got a response from DoorDash, or if they did, there was no resolution.

Several Reddit threads also point to similar complaints.

DoorDash is now a $4 billion company after raising $250 million last month, and serves more than 1,000 cities across the U.S. and Canada.
Continue reading “Article: DoorDash customers say their accounts have been hacked”

Posted on

Article: Interested In Crius Energy Trust (TSE:KWH.UN)’s Upcoming US$0.07 Dividend? You Have 4 Days Left

Article - Media, Publications

Interested In Crius Energy Trust (TSE:KWH.UN)’s Upcoming US$0.07 Dividend? You Have 4 Days Left

Becky Mayes, 22 September 2018

In late January 2021, GameStop experienced a once-in-a-decade squeeze that has captivated the world’s attention. It was a premeditated and programmatic exercise, orchestrated by coordinated stock and option buying across the retail and professional community, resulting in large institutional entities losing billions of dollars. Investment houses with significant short positions did not expect a stock with GameStop’s fundamental profile to increase +2,500% in price over less than three weeks; therefore, they did not have the controls in place to handle the incredible levels of stock and call option purchases. The frenzy drew comments from the White House, provoked a social media crackdown, caused brokerage units to restrict trading, and has led to a Congressional hearing on GameStop on Thursday, February 18th.
Continue reading “Article: Interested In Crius Energy Trust (TSE:KWH.UN)’s Upcoming US$0.07 Dividend? You Have 4 Days Left”

Posted on

Article: Short-seller Andrew Left’s Citron Research says surge in cannabis company Tilray is ‘beyond comprehension’

Article - Media, Publications

Short-seller Andrew Left’s Citron Research says surge in cannabis company Tilray is ‘beyond comprehension’

Lenore Fedow, 19 September 2018

Tilray Inc (NASDAQ:TLRY) set the cannabis space ablaze following an interview with CNBC’s Jim Cramer, sending its shares surging double digits. But short-seller Andrew Left’s Citron Research had some harsh words to share about the Canadian cannabis company.

Citron Research was previously bullish on Tilray following Constellation Brands Inc‘s (NYSE:STZ) additional US$4bn investment in its rival Canopy Growth Inc (NYSE:CGC, TSX:WEED). Left had said it could be the next marijuana company to get a “white knight at a premium to market.”

The short-seller has cast doubt on other cannabis stocks via Twitter Inc (NYSE:TWTR) as well, including Cronos Group Inc (NASDAQ:CRON, CSE:CRON) and Namaste Technologies Inc (CVE:N, OTCQB:NXTTF). Shares of Tilray soared nearly 50% to US$232 in Wednesday pre-market trading.
Continue reading “Article: Short-seller Andrew Left’s Citron Research says surge in cannabis company Tilray is ‘beyond comprehension’”

Posted on

Article: Viceroy alleges Pretium facing personnel ‘exodus’

Article - Media, Publications

Viceroy alleges Pretium facing personnel ‘exodus’

Kip Keen, 31 October 2020

Viceroy Research alleged there was a personnel “exodus” at Pretium Resources Inc. based on a list it compiled of 38 personnel changes at the gold miner in the past year or so. “Our industry consultants have expressed serious discomfort with the extent of the level of resignations, even when considering many staff were assigned on a contract basis for development works,” Viceroy Research said in a report it published Sept. 18.

It said that turnover appears to include Brucejack’s general manager Kevin Torpy who, Viceroy noted, is said to have joined Titan Mining Corp. Titan issued a press release about Torpy’s appointment as vice president of operations on Sept. 17. Viceroy said it appears Torpy left the company “in the wake of the increased scrutiny” that has come from its reports.

The allegations are the latest in Viceroy’s shorting campaign against Pretium. It has published three reports, alleging operational irregularities at Pretium’s Brucejack gold mining operations in British Columbia.
Continue reading “Article: Viceroy alleges Pretium facing personnel ‘exodus’”

Posted on

Article: How Jim Chanos Uses Cynicism, Chutzpah — and a Secret Twitter Account — to Take on Markets (and Elon Musk)

Article - Media, Publications

How Jim Chanos Uses Cynicism, Chutzpah — and a Secret Twitter Account — to Take on Markets (and Elon Musk)

Michelle Celarier, 17 September 2018

It’s a sweltering, 95-degree August day in Manhattan, but Jim Chanos — fresh off a two-week holiday, rocking a sharkskin suit — is pumped: Elon Musk had once again called a hero of the Thai cave rescue a pedophile. It’s 1:30 in the afternoon. Chanos bolts through the door to his office building on West 55th Street, grabs the journalist waiting for him, and, on the elevator ride to his eighth-floor office, fills her in on the latest news. Continue reading “Article: How Jim Chanos Uses Cynicism, Chutzpah — and a Secret Twitter Account — to Take on Markets (and Elon Musk)”

Posted on

Article: Our Final Word on $TLRY before $50

Article - Media, Publications

Our Final Word on $TLRY before $50

Citron Research, 12 September 2018

Tilray management is not stupid. Just seven weeks ago Tilray decided to go public with an offering price of $17. This was done with much deliberation between them and their many bankers. With this price Citron believes they took into consideration all future deals and partnerships that the company had been planning.

The recent cannabis stock rally is a US phenomenon fueled by retail investors. Since August 15, US marijuana stocks Tilray and Cronos have significantly outpaced the performance of their Canadian traded peers.

Due to federal regulation, US listed stocks cannot have any operations in the US without losing their listings, whereas Canadian listed stocks can have US operations. The US will be the largest cannabis market in the world. Today, the California market is over 5x larger than all of Canada. Despite obvious logic, we’ve seen US retail investors pile into the US listed marijuana stocks.
Continue reading “Article: Our Final Word on $TLRY before $50”

Posted on

Article: Pretium – Digging Up Dirt

Article - Media, Publications

Pretium – Digging Up Dirt

Tyler Durden, 06 September 2018

Distorted grades, involvement of SEC sanctioned entities, and high turnover of mineral consultants – Pretium flies many red flags. (PVG:TSX / PVG:NYSE).

Pretium Resources owns and operates the purportedly high-grade Brucejack gold mine in Northwest British Columbia in Canada. Viceroy is short Pretium Resources, as our research suggests its mining results have been distorted and the equity likely worthless as the overindebted company bleeds cash over the next 12 months:

Strathcona Mineral Services Limited (Strathcona), the mining consultancy that famously declared Bre-X to be a fraud, resigned from Pretium’s 2013 bulk sample program later stating, “…they will not have a mine producing 425,000 oz. a year for the next 20 years, as they have been advertising so far”. The entire Pretium investment thesis rests on the validity of the 2013 bulk sample program.
Continue reading “Article: Pretium – Digging Up Dirt”

Posted on

Article: An audience with short-seller Marc Cohodes: ‘You have to be nine-tenths insane to do it’

Article - Media, Publications

An audience with short-seller Marc Cohodes: ‘You have to be nine-tenths insane to do it’

Tom Teodorczuk, 06 September 2018

Marc Cohodes should have made a spectacular killing out of the 2008 financial crisis. Instead the short-seller was caught in the crossfire among the troubled banks, and ended up retreating back to his farm Alder Lane in Northern California and raising chickens: “I was so beyond sick of the whole thing and wanted nothing to do with it.” Continue reading “Article: An audience with short-seller Marc Cohodes: ‘You have to be nine-tenths insane to do it’”

Posted on

Article: Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Cronos Group, Inc. Investors (CRON)

Article - Media, Publications

Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Cronos Group, Inc. Investors (CRON)

BUSINESS WIRE, 04 September 2018

National law firm Glancy Prongay & Murray LLP (“GPM”) announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York on behalf of persons and/or entities that acquired Cronos Group, Inc. (“Cronos” or the “Company”) (NASDAQ: CRON) securities between August 21, 2018, and August 30, 2018, inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants, under the Securities Exchange Act of 1934.

On August 30, 2018, Citron Research published an article entitled “Cronos: The Dark Side of Cannabis Space,” alleging, among other things, that the Company has been “deceiving the investing public by purposely not disclosing the size of its distribution agreements with provinces – unlike every other major cannabis player” and that this was because “the agreements are so small that they could never justify the premium investors are paying for the stock.” On this news, Cronos’ share price fell $3.62 per share, or over $28%, to close at $9.12 per share on August 30, 2018, on unusually heavy trading volume.
Continue reading “Article: Glancy Prongay & Murray LLP Files a Securities Class Action on Behalf of Cronos Group, Inc. Investors (CRON)”

Posted on

Article: The Government’s New Strategy to Crack Down on ‘Spoofing’

Article - Media

The Government’s New Strategy to Crack Down on ‘Spoofing’

Peter J. Henning

New York Times, 4 September 2018

The Justice Department has tried to crack down on traders who try to move markets by entering and quickly canceling orders, conduct that goes by the catchy moniker “spoofing.”

But the government’s early prosecution of the crime has faced a big setback. In just the second trial for spoofing, which the Dodd-Frank Act outlawed, a Connecticut jury acquitted a former trader at UBS of spoofing this spring. That raised questions about whether prosecutors can pursue these cases.

Read full article.

Posted on

Article: Cronos Stock Declines by 30% After Citron Blast

Article - Media, Publications

Cronos Stock Declines by 30% After Citron Blast

NATHAN REIFF, 31 August 2018

Canadian cannabis company Cronos Group, Inc. (CRON) fell by nearly 30% on Thursday following a damning prediction by Citron Research’s famous short-seller Andrew Left. According to MarketWatch, Left published a so-called “reality check” about the company and the future of the legal cannabis industry in general. Along with other factors, most importantly growing concerns about a federal pushback against marijuana legalization, Left’s report seems to have deflated several stocks in the burgeoning space. Along with CRON’s decline, fellow Canadian rivals Canopy Growth Corp. (CGC) and Tilray Inc. (TLRY) both fell, though by much smaller margins. (See also: Marijuana ETF Attracts $22 Million in August)
Continue reading “Article: Cronos Stock Declines by 30% After Citron Blast”

Posted on

Article: Cronos Group, Analyst Respond To Citron’s Short Report

Article - Media, Publications

Cronos Group, Analyst Respond To Citron’s Short Report

Wayne Duggan, 31 August 2018

Citron’s Andrew Left said Thursday morning that Cronos’ agreements are so small that they wouldn’t even come close to justifying the huge gains in the company’s market cap. Left said Cronos lags its Canadian cannabis peers in sales, trades at a steep premium to Canopy Growth Corp CGC 0.42% (which has a beverage deal in place), has a history of product recalls, has no U.S. business and is spending practically nothing on research and development.

“When looking at Cronos relative to other cannabis stocks that have yet to receive a ‘beverage deal,’ Cronos’ sky high valuation looks completely out of whack with fundamentals,” Left said.
Continue reading “Article: Cronos Group, Analyst Respond To Citron’s Short Report”

Posted on

Article: Cronos Group besieged by short-seller Andrew Left’s Citron Research, shares fall and end sharply up Friday

Article - Media, Publications

Cronos Group besieged by short-seller Andrew Left’s Citron Research, shares fall and end sharply up Friday

Ellen Kelleher, 31 August 2018

Shares in the Canadian cannabis group Cronos Group Inc (NASDAQ:CRON) have taken a tumble after the infamous short seller Andrew Left’s firm Citron Research delivered a pessimistic call on the stock. In a note to investors and via its Twitter feed, Citron Research charged that Cronos is the “most overhyped” of all the pot stocks and set a price target of US$3.50 on the Ontario-based company.

The stock fell by 28.4% to US$9.12 in Thursday’s after-hours session. Those losses were extended early on Friday when Cronos stock on the Nasdaq in New York slid another 4.5% to trade at US$8.70 in premarket business. But just as quickly, the stock reversed when trading got going on Friday. Shares climbed to a session peak of US$10.29 before ending 8.33% higher at US$9.88. The share rose 0.4% in after hours trade on Friday to US$9.92. In two days of trading, the stock had swung wildly from its lows to its highs.
Continue reading “Article: Cronos Group besieged by short-seller Andrew Left’s Citron Research, shares fall and end sharply up Friday”

Posted on

Article: Trump’s Top Targets in the Russia Probe Are Experts in Organized Crime

Article - Media, Publications

Trump’s Top Targets in the Russia Probe Are Experts in Organized Crime

Some of President Trump’s favorite targets in the Russia probe have spent their careers in the Justice Department and the FBI investigating organized crime and money laundering, particularly as they pertain to Russia.

Bruce Ohr. Lisa Page. Andrew Weissmann. Andrew McCabe. President Donald Trump has relentlessly attacked these FBI and Justice Department officials as dishonest “Democrats” engaged in a partisan “witch hunt” led by the special counsel determined to tie his campaign to Russia.

Read Full Article

THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?